Cargando…
Is it sufficient to evaluate COVID‐19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?
Autores principales: | Yildirim, Fatma, Yildirim, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329014/ https://www.ncbi.nlm.nih.gov/pubmed/35791040 http://dx.doi.org/10.1111/crj.13520 |
Ejemplares similares
-
Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
por: Salhotra, Ripenmeet
Publicado: (2023) -
Is every microorganism detected in the intensive care unit a nosocomial infection? Isn’t prevention more important than detection?
por: Yildirim, Fatma, et al.
Publicado: (2022) -
Is it sufficient to evaluate only preoperative systemic inflammatory biomarkers to predict postoperative complications after pancreaticoduodenectomy?
por: Demirli Atici, Semra, et al.
Publicado: (2022) -
Not only pulmonary rehabilitation for critically ill patients with COVID-19
por: Estraneo, Anna, et al.
Publicado: (2020) -
Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients
por: Roubinian, Nareg H., et al.
Publicado: (2023)